What Is AKRE? Akre Focus ETF

Most funds that call themselves focused still hold fifty or more positions. AKRE does not. Mastercard at 13.9%, Constellation Software at 12.0%, Brookfield at 8.0%, Visa at 7.4%, Moody's at 7.2%, KKR at 7.1%, Fair Isaac at 6.9%, Roper at 6.8%, Topicus at 6.5% and CoStar at 4.6% account for around 80% of the fund between them.

At that level the arithmetic is unforgiving in both directions. A single holding falling by half takes roughly seven percent off the fund on its own. A single holding doubling adds a comparable amount. There is no diversification cushion, and the fund's outcome over any period is determined by the fortunes of a handful of businesses rather than by market breadth.

The positions are also related in ways a sector breakdown does not capture. Mastercard and Visa are the two halves of a duopoly in card payments, exposed to the same regulatory scrutiny and the same shifts in payment technology, and together they are about 21% of the fund. Constellation Software and Topicus share a lineage, both built on acquiring small vertical-market software businesses, and together they are 18.5%. Considered as economic exposures rather than as tickers, the fund is more concentrated than ten positions suggests.

The sector data reads financials 44% and technology 40%, which sounds like a barbell between banks and software. It is neither. The financials weight is made of Mastercard and Visa, which operate payment networks and take a fee on transaction volume, Moody's, which sells credit ratings and analytics, KKR, an alternative asset manager, and Brookfield, which invests in infrastructure and real assets.

None of those businesses lends money and takes deposit risk, which is what most people picture when they see a large financials weight. What they have in common is closer to a toll road: an established position in a system that others must transact through, generating recurring revenue with limited capital reinvestment. Fair Isaac, classified in technology, fits the same description through credit scoring.

This is the strategy's actual thesis, and it is more coherent than the sector labels make it look. The fund is built around businesses with entrenched positions, pricing power and high returns on the capital they employ. Whether that thesis works out is a separate matter from whether the portfolio is internally consistent, and it clearly is.

At 0.98%, AKRE is by a wide margin the most expensive fund in this comparison, and it is priced like a traditional active manager because that is what it is. The 2009 inception date reflects a predecessor mutual fund rather than an ETF that traded from that year. The fee applies annually to a portfolio that could, in principle, be replicated by buying ten shares directly, which is a comparison anyone paying it should make consciously.

The dividend yield is 0.00%. The holdings largely reinvest or buy back shares rather than distributing, and the strategy makes no attempt to generate income. Anything a holder needs to withdraw has to come from selling shares.

The risks follow from the design. Concentration means single-company outcomes dominate. The payments duopoly faces persistent regulatory attention on interchange fees and competition from newer payment rails. The software acquirers depend on continuing to find businesses to buy at sensible prices, which becomes harder as they grow. This is a poor fit as a core holding, a poor fit for anyone who needs income, and a poor fit for an investor who would be uncomfortable seeing a single company move their portfolio by several percent in a day.

Approximate weights as of August 2026. Each ticker links to its individual stock guide in Walnut.

There are three common ways to get AKRE exposure. Buy shares (or fractional shares) of AKRE directly at any major broker that lists it. Hold it as a core position and layer more concentrated ideas on top. Or build it into a thematic portfolio in Walnut, so AKRE sits alongside other holdings that express the same thesis, with target weights you can rebalance toward. AKRE trades like a stock during market hours, so you buy it the same way you would any listed share.

New to buying funds? See how to buy an ETF, step by step.

Whether AKRE is a good buy depends less on any single call and more on your time horizon and what you already hold: it tracks Actively managed, no tracked index, so the real question is whether you want that exposure in your mix and at what weight. We walk through valuation, concentration, and what would have to be true for it to outperform from here in is AKRE a buy?

AKRE gives you Actively managed, no tracked index exposure in one ticker at a 0.98% expense ratio. Most investors use it as a core holding and layer more concentrated thematic portfolios on top.

Whether AKRE is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, concentration, and what would have to be true for it to outperform from here in is AKRE a buy?

AKRE yields 0.00% as of August 2026, paid by passing through the dividends of its underlying holdings. For the payout schedule, history, and how the distributions are taxed, see AKRE dividend: yield and schedule.

New to funds like AKRE? Start with what an ETF is, then how to buy an ETF, or browse the full guide to ETF investing.